Trademark applications and grants for Debiopharm International Sa. Debiopharm International Sa has 14 trademark applications. The latest application filed is for "FIBROTRAP"
State Incorporated | SWITZERLAND |
Entity Type | Société anonyme |
Address | Chemin Messidor 5-7, CP 5911 Lausanne SWITZERLAND CH1002 |
Patent Application | Date |
---|---|
AFABICIN FORMULATION, METHOD FOR MAKING THE SAME AND USES THEREOF 20220142993 - 17/430616 Decrette; Marie ;   et al. | 2022-05-12 |
COMBINATION PRODUCT FOR THE TREATMENT OF CANCER 20220096436 - 17/423370 Szyldergemajn Altman; Sergio Adrian ;   et al. | 2022-03-31 |
COMBINATION TREATMENT OF HIV INFECTIONS 20220016079 - 17/296462 Vuagniaux; Gregoire ;   et al. | 2022-01-20 |
DOSING REGIMENS FOR TREATMENT OF SOLID TUMORS HAVING ONE OR MORE GENETIC ALTERATIONS IN FGFR1, FGFR2, AND/OR FGFR3 20210205272 - 17/055886 ZANNA; Claudio ;   et al. | 2021-07-08 |
COMBINATION PRODUCT FOR THE TREATMENT OF CANCER 20210198365 - 16/757178 Vuagniaux; Gregoire ;   et al. | 2021-07-01 |
NCAGE Code | SCGE0 | DEBIOPHARM INTERNATIONAL SA |
CAGE Code | SCGE0 | DEBIOPHARM INTERNATIONAL SA |
S.A.M. Registration | SCGE0 [481548477] | DEBIOPHARM INTERNATIONAL SA |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.